You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘type 2 diabetes’
September 2006
Br J Cardiol 2006;13:347-50
Should cardiologists be interested in albuminuria?
Excretion of excess urinary albumin is a marker of generalised endothelial dysfunction and both progressive renal disease and cardiovascular events in those with and without...
March 2006
Br J Cardiol 2006;13:113-20
A new therapeutic target: the CB1 receptors of the endocannabinoid system and visceral fat
A constant abundance of food and a sedentary lifestyle has led to an increasing prevalence of obesity in the United Kingdom. This has resulted in...
January 2006
Br J Cardiol 2006;13:66-70
Heart disease prevention – what place for the glitazones?
This paper considers the role for glitazones in the treatment of type 2 diabetes following publication of the PROactive study, the first major outcome study...
March 2004
Br J Cardiol 2004;11:138-43
Will prevention of type 2 diabetes reduce the future burden of cardiovascular disease? The evidence base today
The prevalence of type 2 diabetes is set to double over the next 25 years, leading to substantial morbidity and mortality, particularly from macrovascular diabetic...
March 2004
Br J Cardiol 2004;11:129-36
Evolution of the HMG CoA reductase inhibitors (statins) in cardiovascular medicine
Recent trials have broadened the evidence base for statin use. It has now been documented that these drugs are effective agents not only in the...
November 2003
Br J Cardiol 2003;10:462-8
Modified-release nicotinic acid for dyslipidaemia: novel formulation improves tolerability and optimises efficacy
Data from epidemiological and intervention studies have conclusively shown that a low level of high-density lipoprotein cholesterol (HDL-C) is an important risk factor for cardiovascular...
March 2003
Br J Cardiol 2003;10:128-36
Antidiabetic drugs
Achieving good glycaemic control is an important part of the treatment strategy to minimise vascular complications in diabetes. An expanding range of differently acting oral...
February 2002
Br J Cardiol 2002;9:115-19
United Kingdom Prospective Diabetes Study: implications for metformin
One of the purposes of the United Kingdom Prospective Diabetes Study (UKPDS) was to compare the efficacy of different antidiabetic drugs in the long-term treatment...